Poseida Therapeutics
PSTX
$15.10
Share price
0.00%
Change (1 day)
208.58%
Change (1 year)
P/S ratio for Poseida Therapeutics (PSTX)
P/S ratio as of March 2025 (TTM): 6.14
According to Poseida Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 10.6. At the end of 2024 the company had a P/S ratio of 1.87.
P/S ratio history for Poseida Therapeutics from 2020 to 2024
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2024 | 1.87 | -62.4% |
| 2023 | 4.97 | 42.25% |
| 2022 | 3.49 | -74.39% |
| 2021 | 13.6 | |
| 2020 | N/A |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 | N/A | N/A | 🇺🇸 USA |